Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1967 Feb 25;1(5538):449–450.

Prognosis in breast cancer.

PMCID: PMC1840914  PMID: 6017517

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BULBROOK R. D., HAYWARD J. L., THOMAS B. S. THE RELATION BETWEEN THE URINARY 17-HYDROXYCORTICOSTEROIDS AND 11-DEOXY-17-OXOSTEROIDS AND THE FATE OF PATIENTS AFTER MASTECTOMY. Lancet. 1964 May 2;1(7340):945–947. doi: 10.1016/s0140-6736(64)91741-6. [DOI] [PubMed] [Google Scholar]
  2. JURET P., HAYEM M., FLAISLER A. A PROPOS DE 150 IMPLANTATIONS D'YTTRIUM RADIO-ACTIF INTRA-HYPOPHYSAIRES DANS LE TRAITEMENT DU CANCER DU SEIN 'A UN STADE AVANC'E. TECHNIQUE; BILAN CLINIQUE; INDICATIONS. J Chir (Paris) 1964 Apr;87:409–433. [PubMed] [Google Scholar]
  3. Miller H., Durant J. A., Jacobs A. G., Allison J. F. Alternative discriminating function for determining hormone dependency of breast cancer. Br Med J. 1967 Jan 21;1(5533):147–149. doi: 10.1136/bmj.1.5533.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Philip J. F. Results of treatment of breast cancer at Aberdeen Royal Infirmary 1940-55. Br Med J. 1967 Feb 11;1(5536):323–331. doi: 10.1136/bmj.1.5536.323. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES